Autoimmun Rev:系统性红斑狼疮妇女导致生育异常的相关因素

2022-01-14 从医路漫漫 MedSci原创

系统性红斑狼疮(SLE)是一种慢性自身免疫性疾病,主要影响育龄期成年女性。

背景:系统性红斑狼疮(SLE)是一种慢性自身免疫性疾病,主要影响育龄期成年女性。在这些患者中,生育能力是一个值得关注的领域,因为与疾病相关的因素(例如更高的疾病活动,狼疮发作或疾病相关的损伤),慢性疾病的社会心理影响以及药物暴露可能会损害性腺功能。生育率是所有风湿病学家在SLE妇女管理中应考虑的一个重要方面,以便选择适当的治疗方法来保证和保护其生育能力。SLE卵巢功能衰竭的病理生理机制尚未完全确定,但可合理涉及外在因素(如治疗相关)和内在因素(如疾病相关)的共同影响。环磷酰胺(CYC)是一种免疫抑制药物,用于存在严重的主要器官受累,包括狼疮性肾炎和急性神经精神疾病(NP)。一些研究表明,SLE患者的环磷酰胺治疗与月经紊乱/闭经/卵巢早衰(POF)有关,与治疗时的累积剂量和患者年龄有关。在使用该治疗方法之前,应考虑使用促性腺激素释放激素类似物(GnRH-a)保留生育的能力。其他免疫抑制剂与生育异常的关系未知。目的:本系统文献综述(SLR)旨在探讨育龄期SLE妇女患者与生育结果相关的临床、激素、血清学和治疗因素。

方法:本SLR是按照系统评价和荟萃分析(PRISMA)的首选报告项目进行的。都经过Pubmed、EMBASE、Scopus和Cochrane图书馆的所有英文文章(1972 - 2021年4月30日)筛选。研究选择和数据收集由两名独立的审稿人完成。所有数据都是使用标准化模板提取的。使用NIH偏倚风险工具评估纳入研究的偏倚风险。

结果:在评估的789篇摘要中,我们纳入了46项研究,其中1项SLR研究、16项横断面研究、18项队列研究、10项观察性研究和1个病例系列研究,数据涉及4704例患者(平均年龄31.5±3.7岁,病程83.27±38.3个月)。研究中采用的卵巢早衰(POF)的定义因考虑闭经的月数和闭经的发病年龄而异。与POF发生相关的临床因素是开始治疗时年龄较大,以及SLE发病时年龄较大。19项研究报告称,环磷酰胺暴露(CYC)及其累积剂量影响SLE妇女的性腺功能,导致闭经和POF。与CYC相比,霉酚酸盐、硫唑嘌呤、钙调磷酸酶抑制剂和类固醇与POF相关的风险较低。与未接受GnRH-a治疗的患者相比,CYC和GnRH-a联合治疗的患者发生POF的频率较低(风险比0.798,95%-CI [0.1417;0.5525])。11项研究评估了损伤累积和疾病活动对卵巢储备的影响,但证据相矛盾。最后,18项研究调查了激素和血清学因素的暴露情况,其中Anti-Müllerian激素和黄体抗体都与POF无关。

结论:关于育龄SLE妇女生育相关因素的最强证据仍然是CYC治疗,以及其累积剂量。激素和血清学因素似乎不会影响生育结果,但它们可能用于评估生育状况,特别是在使用特定疾病的药物治疗期间。

原文出处:Giambalvo S,  Garaffoni C,  Silvagni E,et al.Factors associated with fertility abnormalities in women with systemic lupus erythematosus: a systematic review and meta-analysis.Autoimmun Rev 2022 Jan 04

 

版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (5)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=2017331, encodeId=3bec201e3314a, content=<a href='/topic/show?id=9760e69058c' target=_blank style='color:#2F92EE;'>#系统性#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=48, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=76905, encryptionId=9760e69058c, topicName=系统性)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=2b9b368, createdName=qingrejiedu, createdTime=Wed Apr 27 17:45:01 CST 2022, time=2022-04-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1387488, encodeId=153f138e4882b, content=<a href='/topic/show?id=8a3a6814425' target=_blank style='color:#2F92EE;'>#狼疮#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=68144, encryptionId=8a3a6814425, topicName=狼疮)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7a6e2500005, createdName=sunrural_42825357, createdTime=Sat Jan 15 13:45:01 CST 2022, time=2022-01-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1436317, encodeId=bfa1143631e32, content=<a href='/topic/show?id=22f8e71238d' target=_blank style='color:#2F92EE;'>#红斑#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=43, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=77123, encryptionId=22f8e71238d, topicName=红斑)], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/aLGWoFXAyMbIu3qymFOyheQLjPSX3OUs5GmkyBlcCOwTPIeq3why9NGibxxUqYo6hcx8qZLHZFgNPnBK1yzWeOFpyg2OnWOt0/0, createdBy=fa4716, createdName=zhouqu_8, createdTime=Sat Jan 15 13:45:01 CST 2022, time=2022-01-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1457553, encodeId=b72d145e553ff, content=<a href='/topic/show?id=4159e25296d' target=_blank style='color:#2F92EE;'>#相关因素#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=41, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=72529, encryptionId=4159e25296d, topicName=相关因素)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=19655942413, createdName=zzc2213, createdTime=Sat Jan 15 13:45:01 CST 2022, time=2022-01-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1184177, encodeId=6eb711841e713, content=学习了<a href='/topic/show?id=23e3454e353' target=_blank style='color:#2F92EE;'>#学习#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=66, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=45473, encryptionId=23e3454e353, topicName=学习)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6c026465911, createdName=ms7000000023254968, createdTime=Fri Jan 14 11:02:21 CST 2022, time=2022-01-14, status=1, ipAttribution=)]
  2. [GetPortalCommentsPageByObjectIdResponse(id=2017331, encodeId=3bec201e3314a, content=<a href='/topic/show?id=9760e69058c' target=_blank style='color:#2F92EE;'>#系统性#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=48, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=76905, encryptionId=9760e69058c, topicName=系统性)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=2b9b368, createdName=qingrejiedu, createdTime=Wed Apr 27 17:45:01 CST 2022, time=2022-04-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1387488, encodeId=153f138e4882b, content=<a href='/topic/show?id=8a3a6814425' target=_blank style='color:#2F92EE;'>#狼疮#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=68144, encryptionId=8a3a6814425, topicName=狼疮)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7a6e2500005, createdName=sunrural_42825357, createdTime=Sat Jan 15 13:45:01 CST 2022, time=2022-01-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1436317, encodeId=bfa1143631e32, content=<a href='/topic/show?id=22f8e71238d' target=_blank style='color:#2F92EE;'>#红斑#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=43, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=77123, encryptionId=22f8e71238d, topicName=红斑)], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/aLGWoFXAyMbIu3qymFOyheQLjPSX3OUs5GmkyBlcCOwTPIeq3why9NGibxxUqYo6hcx8qZLHZFgNPnBK1yzWeOFpyg2OnWOt0/0, createdBy=fa4716, createdName=zhouqu_8, createdTime=Sat Jan 15 13:45:01 CST 2022, time=2022-01-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1457553, encodeId=b72d145e553ff, content=<a href='/topic/show?id=4159e25296d' target=_blank style='color:#2F92EE;'>#相关因素#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=41, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=72529, encryptionId=4159e25296d, topicName=相关因素)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=19655942413, createdName=zzc2213, createdTime=Sat Jan 15 13:45:01 CST 2022, time=2022-01-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1184177, encodeId=6eb711841e713, content=学习了<a href='/topic/show?id=23e3454e353' target=_blank style='color:#2F92EE;'>#学习#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=66, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=45473, encryptionId=23e3454e353, topicName=学习)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6c026465911, createdName=ms7000000023254968, createdTime=Fri Jan 14 11:02:21 CST 2022, time=2022-01-14, status=1, ipAttribution=)]
  3. [GetPortalCommentsPageByObjectIdResponse(id=2017331, encodeId=3bec201e3314a, content=<a href='/topic/show?id=9760e69058c' target=_blank style='color:#2F92EE;'>#系统性#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=48, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=76905, encryptionId=9760e69058c, topicName=系统性)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=2b9b368, createdName=qingrejiedu, createdTime=Wed Apr 27 17:45:01 CST 2022, time=2022-04-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1387488, encodeId=153f138e4882b, content=<a href='/topic/show?id=8a3a6814425' target=_blank style='color:#2F92EE;'>#狼疮#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=68144, encryptionId=8a3a6814425, topicName=狼疮)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7a6e2500005, createdName=sunrural_42825357, createdTime=Sat Jan 15 13:45:01 CST 2022, time=2022-01-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1436317, encodeId=bfa1143631e32, content=<a href='/topic/show?id=22f8e71238d' target=_blank style='color:#2F92EE;'>#红斑#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=43, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=77123, encryptionId=22f8e71238d, topicName=红斑)], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/aLGWoFXAyMbIu3qymFOyheQLjPSX3OUs5GmkyBlcCOwTPIeq3why9NGibxxUqYo6hcx8qZLHZFgNPnBK1yzWeOFpyg2OnWOt0/0, createdBy=fa4716, createdName=zhouqu_8, createdTime=Sat Jan 15 13:45:01 CST 2022, time=2022-01-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1457553, encodeId=b72d145e553ff, content=<a href='/topic/show?id=4159e25296d' target=_blank style='color:#2F92EE;'>#相关因素#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=41, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=72529, encryptionId=4159e25296d, topicName=相关因素)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=19655942413, createdName=zzc2213, createdTime=Sat Jan 15 13:45:01 CST 2022, time=2022-01-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1184177, encodeId=6eb711841e713, content=学习了<a href='/topic/show?id=23e3454e353' target=_blank style='color:#2F92EE;'>#学习#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=66, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=45473, encryptionId=23e3454e353, topicName=学习)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6c026465911, createdName=ms7000000023254968, createdTime=Fri Jan 14 11:02:21 CST 2022, time=2022-01-14, status=1, ipAttribution=)]
    2022-01-15 zhouqu_8
  4. [GetPortalCommentsPageByObjectIdResponse(id=2017331, encodeId=3bec201e3314a, content=<a href='/topic/show?id=9760e69058c' target=_blank style='color:#2F92EE;'>#系统性#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=48, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=76905, encryptionId=9760e69058c, topicName=系统性)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=2b9b368, createdName=qingrejiedu, createdTime=Wed Apr 27 17:45:01 CST 2022, time=2022-04-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1387488, encodeId=153f138e4882b, content=<a href='/topic/show?id=8a3a6814425' target=_blank style='color:#2F92EE;'>#狼疮#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=68144, encryptionId=8a3a6814425, topicName=狼疮)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7a6e2500005, createdName=sunrural_42825357, createdTime=Sat Jan 15 13:45:01 CST 2022, time=2022-01-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1436317, encodeId=bfa1143631e32, content=<a href='/topic/show?id=22f8e71238d' target=_blank style='color:#2F92EE;'>#红斑#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=43, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=77123, encryptionId=22f8e71238d, topicName=红斑)], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/aLGWoFXAyMbIu3qymFOyheQLjPSX3OUs5GmkyBlcCOwTPIeq3why9NGibxxUqYo6hcx8qZLHZFgNPnBK1yzWeOFpyg2OnWOt0/0, createdBy=fa4716, createdName=zhouqu_8, createdTime=Sat Jan 15 13:45:01 CST 2022, time=2022-01-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1457553, encodeId=b72d145e553ff, content=<a href='/topic/show?id=4159e25296d' target=_blank style='color:#2F92EE;'>#相关因素#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=41, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=72529, encryptionId=4159e25296d, topicName=相关因素)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=19655942413, createdName=zzc2213, createdTime=Sat Jan 15 13:45:01 CST 2022, time=2022-01-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1184177, encodeId=6eb711841e713, content=学习了<a href='/topic/show?id=23e3454e353' target=_blank style='color:#2F92EE;'>#学习#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=66, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=45473, encryptionId=23e3454e353, topicName=学习)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6c026465911, createdName=ms7000000023254968, createdTime=Fri Jan 14 11:02:21 CST 2022, time=2022-01-14, status=1, ipAttribution=)]
  5. [GetPortalCommentsPageByObjectIdResponse(id=2017331, encodeId=3bec201e3314a, content=<a href='/topic/show?id=9760e69058c' target=_blank style='color:#2F92EE;'>#系统性#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=48, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=76905, encryptionId=9760e69058c, topicName=系统性)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=2b9b368, createdName=qingrejiedu, createdTime=Wed Apr 27 17:45:01 CST 2022, time=2022-04-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1387488, encodeId=153f138e4882b, content=<a href='/topic/show?id=8a3a6814425' target=_blank style='color:#2F92EE;'>#狼疮#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=68144, encryptionId=8a3a6814425, topicName=狼疮)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7a6e2500005, createdName=sunrural_42825357, createdTime=Sat Jan 15 13:45:01 CST 2022, time=2022-01-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1436317, encodeId=bfa1143631e32, content=<a href='/topic/show?id=22f8e71238d' target=_blank style='color:#2F92EE;'>#红斑#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=43, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=77123, encryptionId=22f8e71238d, topicName=红斑)], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/aLGWoFXAyMbIu3qymFOyheQLjPSX3OUs5GmkyBlcCOwTPIeq3why9NGibxxUqYo6hcx8qZLHZFgNPnBK1yzWeOFpyg2OnWOt0/0, createdBy=fa4716, createdName=zhouqu_8, createdTime=Sat Jan 15 13:45:01 CST 2022, time=2022-01-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1457553, encodeId=b72d145e553ff, content=<a href='/topic/show?id=4159e25296d' target=_blank style='color:#2F92EE;'>#相关因素#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=41, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=72529, encryptionId=4159e25296d, topicName=相关因素)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=19655942413, createdName=zzc2213, createdTime=Sat Jan 15 13:45:01 CST 2022, time=2022-01-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1184177, encodeId=6eb711841e713, content=学习了<a href='/topic/show?id=23e3454e353' target=_blank style='color:#2F92EE;'>#学习#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=66, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=45473, encryptionId=23e3454e353, topicName=学习)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6c026465911, createdName=ms7000000023254968, createdTime=Fri Jan 14 11:02:21 CST 2022, time=2022-01-14, status=1, ipAttribution=)]
    2022-01-14 ms7000000023254968

    学习了#学习#

    0

相关资讯

太难了!得了“不死的癌症”红斑狼疮,“真癌症”的发生风险竟也会显著升高!

ARTHRITIS RES THER:系统性红斑狼疮患者恶性肿瘤风险增加:韩国基于人群的队列研究

ARD:宏基因组关联研究揭示了日本系统性红斑狼疮患者肠道微生物群的疾病特异性景观

本研究旨在通过全面的宏基因组范围关联研究 (MWAS) 以及相应的综合分析,揭示肠道微生物群与SLE 相关的变化及其与宿主的相互作用。

CHMP推荐Saphnelo治疗系统性红斑狼疮

系统性红斑狼疮(SLE)是一种复杂的自身免疫性疾病,可以影响任何身体器官。SLE患者经常经历疾病控制不足、长期器官损伤和与健康相关的生活质量差。

A&R: 雌激素诱导的hsa-miR-10b-5p在系统性红斑狼疮患者的T细胞中升高,并下调富含丝氨酸/精氨酸的剪接因子1

本研究旨在研究雌激素的作用和SRSF1的转录后调控机制在T细胞和SLE中的作用。

结缔组织疾病中的肺动脉高压:新证据?新挑战?

肺动脉高压是系统性硬化症、混合性结缔组织病和系统性红斑狼疮等不同结缔组织疾病的致命并发症。

ARD: 羟氯喹减少或停药后的发作:系统性狼疮国际合作诊所 (SLICC) 初始队列的结果

HCQ减量/停药后SLE发作风险高于HCQ维持。维持、减少或停止HCQ的决定可能会对特定亚组产生不同的影响,包括使用泼尼松和/或教育程度低的亚组。